Skip to main content
. Author manuscript; available in PMC: 2021 Jan 18.
Published in final edited form as: J Neurointerv Surg. 2017 Feb 14;10(1):93–97. doi: 10.1136/neurintsurg-2016-012911

Figure 2.

Figure 2

Severity of aneurysm development in mouse cerebral aneurysm model. (A) Anti-CXCL1 treated mice did not develop aneurysms at 2 weeks compared with IgG treated mice. Scale bar=2 mm. (B) Aneurysm development in the IgG control group displayed varying levels of severity that were significantly different from anti-CXCL1 treated mice when scored using (C) the 5 point grading scale (circle=aneurysm, dotted circle=ruptured aneurysm) (p=0.0046 by Mann–Whitney test, *p<0.05).